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■ RESEARCH LETTER ■
A 24-year-old, gravida 4, para 1, woman was referred to
the hospital at 16 weeks of gestation because of fetal
structural abnormalities. Level II ultrasound revealed 
a fetus with intrauterine growth restriction (IUGR), 
a normal amount of amniotic fluid, a small non-cystic
placenta, a singleton fetus with a crown-rump length 
of 5.5 cm (12 weeks’ equivalent), alobar holoprosen-
cephaly (HPE), and relative macrocephaly with an
anteroposterior diameter about half of the crown-rump
length (Figure 1). The urinary tracts were normal. Amnio-
centesis revealed a karyotype of 69,XXX. The pregnancy
was subsequently terminated. A 40-g female fetus was
delivered with a small placenta (Figure 2). At birth, the
proband displayed relative macrocephaly, premaxillary
agenesis, median facial cleft, and a small thin trunk. The
placenta was small and non-cystic. Postnatal cytoge-
netic analysis of the fetal skin revealed a karyotype of
69,XXX (Figure 3). DNA was obtained from the uncul-
tured tissues of fetal skin and parental blood. Quantita-
tive fluorescent polymerase chain reaction (QF-PCR)
assays and polymorphic short tandem repeat markers
for chromosomes 13, 18 and 21 were used for deter-
mination of the parental origin of the extra chromo-
somes (Table). The skin specimen showed a diallelic
pattern with a dosage ratio of 1:2 (paternal allele to
maternal allele ratio) for the chromosome 21-specific
and chromosome 18-specific pericentromeric markers,
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Accepted: July 2, 2009 Figure 2. The fetus and the placenta at birth.
Figure 1. Prenatal ultrasound of the fetus at 16 weeks of ges-
tation shows a relative large head and brain malformations.
and a triallelic pattern with a dosage ratio of 1:1:1 (pater-
nal allele to maternal allele to maternal allele ratio) for
the chromosome 13-specific non-pericentromeric and
distal markers (Figure 4). The molecular data indi-
cated a maternal origin of digynic triploidy. Triploidy
in the fetal tissues in this case was most likely the result
of meiosis II nondisjunction error of oogenesis. A recom-
bination was observed. There were reductions to homozy-
gosity at the pericentromeric markers and no reduction
to homozygosity at the more distal loci.
Our case represents a rare occurrence of triploidy
with HPE presenting at 16 weeks of gestation. Triploidy
occurs in about 1% of all conceptions [1]. The preva-
lence of triploidy has been estimated to be 1 per 50 at
6 gestational weeks, 1 per 350 at 8 gestational weeks,
1 per 1,000 at 10 gestational weeks, 1 per 3,500 at 12
gestational weeks, 1 per 10,000 at 14 gestational weeks,
1 per 30,000 at 16 gestational weeks, 1 per 100,000 
at 18 gestational weeks, and 1 per 250,000 at 20 ges-
tational weeks [2]. Jauniaux et al [3] reported HPE in
2.9% (2/70) of cases with triploidy at 13–29 weeks 
of gestation, and Mittal et al [4] reported HPE in 
5% (1/20) of cases with triploidy at 14–25 weeks of
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Table. Genotypic information of the fetus and the parents at short tandem repeat (STR) markers specific for 
chromosomes 13, 18 and 21 by quantitative fluorescent polymerase chain reaction assays*
STRs Location Father Mother Proband
D21S1434 21p11.2 182,194 190,198 182,190,190
D18S847 18q12.1 210,226 218 210,218,218
D18S1369 18q12.2 180 172 172,172,180
D13S1491 13q13.3 146,154 150,154 146,150,154
D13S1492 13q21.1 159 147,159 147,159,159
D13S766 13q33.1 129,133 121,125 121,125,129
*Alleles (basepair sizes) are listed below each individual.
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Figure 4. Representative electrophoretogram of quantitative
fluorescent polymerase chain reaction assays at short tan-
dem repeat markers for chromosomes 13, 18 and 21 using
fetal tissues and parental blood. With the pericentromeric
markers D21S1434 and D18S1369, the fetus showed a dial-
lelic pattern with a dosage ratio of 1:2 (paternal allele to
maternal allele ratio). With the non-pericentromeric and dis-
tal marker D13S766, the fetus showed a triallelic pattern
with a dosage ratio of 1:1:1 (paternal allele to maternal
allele to maternal allele ratio). Digynic triploidy in this fetus
was most likely the result of meiosis II nondisjunction error
of oogenesis.
gestation. Chen et al [5] reported that triploidy repre-
sented 6.8% (5/73) of cases with fetal HPE detected 
in the second and third trimesters. However, Jauniaux 
et al [6] reported HPE in 22.2% (4/18) of cases with
triploidy at 10–14 weeks of gestation, and Philipp et al
[7] reported HPE in 11.1% (2/18) of cases with
triploidy at 10–15 weeks of gestation. The frequency of
HPE in prenatally diagnosed triploidy varies with ges-
tational age at diagnosis. When the diagnosis of
triploidy is made in early pregnancy, the frequency of
HPE increases. The low frequency of triploidy in fetal
HPE detected in the second trimester and beyond is
because most of the conceptuses with triploidy abort
in the first trimester and only a few survive to the second
trimester [5].
The prevalence of HPE in registered births is about
1.2 per 10,000 [8,9]. The prevalence of HPE in the sec-
ond trimester is about 1 per 8,000 [9]. Variable types
of HPE range from severe alobar HPE with cyclopia,
ethmocephaly, cebocephaly or premaxillary agenesis,
to microforms with microcephaly, corpus callosum
agenesis/dysgenesis, mental retardation, ocular hyper-
telorism only, or a single maxillary central incisor [10].
Chromosomal aberrations, Mendelian mutations, 
X-linked inheritance and teratogens are well known
causes of HPE. Cytogenetic abnormalities have been
reported in 24–25% of live births born with HPE, tri-
somy 13 being the most common [11]. Reported chro-
mosomal abnormalities associated with HPE include
trisomy 13, trisomy 18, triploidy, del(2p), dup(3p),
del(7q), del(13q), del(18p), del(21q), and interstitial
deletion of 14q13 [10,12–15]. Blaas et al [16] found
chromosomal abnormalities in 36.7% (11/30) of fetuses
with prenatally detected HPE including trisomy 13
(n=5), r(13) (n=1), del(13q) (n=1), triploidy (n=1),
partial monosomy 14q (n=1), partial monosomy 11p
(n=1), and t(8;14)(q21.1;q24.1) (n=1).
In the present case, digynic triploidy occurred in the
fetus of a relatively young woman. Molecular analysis
showed that the digynic triploidy was caused by an error
in the second meiotic division of oogenesis. Digynic
triploidy most often arises from fertilization by a normal
haploid sperm with a primary oocyte or with a diploid
ovum. The diploid ovum results from an error during
meiosis I or II, or from retention of the second polar
bodies. Digynic triploidy is characterized by marked
asymmetric IUGR, a small placenta without partial
mole, and a variety of congenital malformations that
may affect almost every organ system. Diandric triploidy
is characterized by normal fetal growth or a mild degree
of symmetric growth restriction, normal or partial molar
placenta, and a range of malformations similar to those
of digynic triploidy. In the fetal period, cases with digynic
triploidy are far more commonly observed than those
with diandric triploidy [17,18]. Ultrasonography is the
first choice of prenatal investigation of triploid fetuses,
and prenatal magnetic resonance imaging may provide
excellent anatomic details and a large field of view,
especially under the circumstance of oligohydramnios
[19]. This presentation highlights the usefulness of
QF-PCR in the rapid diagnosis of digynic triploidy 
following prenatal sonographic diagnosis of IUGR, 
relative macrocephaly, and HPE.
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